COVID-19: A Brighter Future for Medical Research?
COVID-19 has highlighted the inefficiencies that exist in clinical research, as well as the frailties of the current publishing system. This blog examines two prominent examples from the pandemic.
COVID-19 has highlighted the inefficiencies that exist in clinical research, as well as the frailties of the current publishing system. This blog examines two prominent examples from the pandemic.
Heidi Gardner is part of a team of researchers working on the PRioRiTy II project, a research project aiming to identify the most important things that we currently don’t know about things that affect whether people stay involved in trial. Read more about the project here and then have your say in identifying the top 10 questions about trial retention that still need answering.
Publication bias remains a problem in health research. This blog by Andrés explores the issues we face and provides detail of the initiatives designed to address the problem.
This blog provides a detailed overview of the concept of ‘blinding’ in randomised controlled trials (RCTs). It covers what blinding is, common methods of blinding, why blinding is important, and what researchers might do when blinding is not possible. It also explains the concept of allocation concealment.
Currently decisions made on treatment of bronchiectasis are based on guidelines which have a very poor evidence base. Read more to find out!
Heidi reviews ‘Systematic Reviews in Health Care: A Practical Guide’ written by Paul Glasziou, Les Irwig, Chris Bain and Graham Colditz
Randomised Controlled Trials (RCTs) are central to evidence-based healthcare; but they themselves are riddled with inefficiency. Trial Forge aims to change that.
Register to become an S4BE Contributor